Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma
Clinical trial NCT04091503 · COMPLETED
Trial details
- NCT number
- NCT04091503
- Sponsor
- Center Trials & Treatment Europe
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-20
- Primary completion
- 2022-09-21
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.